Business
Seminar Presentation
Seminar Presentation.
About this update from Physiomics Plc
[{"type":"text","content":"\n RNS Number : 7821Q Physiomics PLC 20 April 2009 \n \n20 April 2009 \nPhysiomics plc \n('Physiomics' or 'the Company')\nPhysiomics to present on Chronotherapy at the Annual Meeting of American\nAssociation for Cancer Research ('AACR')\n\nPhysiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the 100th annual meeting of the American Association for Cancer Research, taking place at the Colorado Convention Centre, Denver, Colorado, USA on 18-22 April 2009. Dr Adam Hardy, senior scientist at Physiomics, will present a development update on the Company's chronotherapy research program, as part of the EU funded TEMPO (Temporal Genomics for Tailored Chronotherapeutics) project. Physiomics' poster will include for the first time results obtained from the Company's comprehensive computer model featuring cell proliferation and cell death regulated by the circadian clock running in the Company's proprietary simulation technology, 'SystemCell®'. The Company intends to use this model to predict new optimal drug schedules which could be commercially exploited by the Company.\n\nThe abstract ('Chronotherapy: Seliciclib dosing schedules determined using a detailed computational cancer model', No 3300) will be published in the 2009 Proceedings of the AACR and will be presented in the poster session 'Cancer Systems Biology', scheduled for 8:00am on 21st April.\n\nMore information about the conference may be found at http://www.aacr.org/home/scientists/meetings--workshops/aacr-100th-annual-meeting-2009.aspx\n\nEnquiries:\n\nPhysiomics plc \nDr Christophe Chassagnole, COO \n+44 (0)1865 784980\n\nWH Ireland Limited\nDavid Youngman/Katy Mitchell\n+44 (0) 161 832 2174\n\n\nAbout TEMPO project (LSHG-CT-2006-037543)\nIn 2006, Physiomics was ...